	Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets. PeerJ Shen X, Wang R, Su F, Guo J, Zhao D, Yuan F, Zhang T, Hou X. PMID: 41635813 [PubMed - indexed for MEDLINE]
	Medical expenses and influencing factors in lung cancer patients: a comparative analysis between surgical and non-surgical cases from Xiamen, China. Front Public Health Chen L, Luo W, Liu J, Lin M, Zhuang Z. PMID: 41635439 [PubMed - indexed for MEDLINE]
	Prediction of non-small cell lung cancer subtypes is possible through restricted spectrum imaging. Front Oncol Shen L, Zhang Y, Huang Z, Dai B, Yang Y, Wang Z, Yu X, Meng N, Fu FF. PMID: 41635406 [PubMed]
	Comparison of the efficacy based on clinicopathological characteristics and the safety of first-line treatments for patients with advanced ALK rearrangement non-small cell lung cancer: a network meta-analysis. Front Oncol Li Y, Wen Y, Zhang W, Zhao Y, Zhou L, Zeng X, Kang X, Li L. PMID: 41635404 [PubMed]
	Dual-correction robotic bronchoscopy system with ultra-thin catheter for diagnosing challenging peripheral pulmonary nodules: A multi-centre prospective trial. Pulmonology You Z, Huang J, Wang F, Xu L, Liu J, Li H, Tang J, Li W, Li Z, Liu Y, Bai Y, Li S, Zhong C. PMID: 41635252 [PubMed - indexed for MEDLINE]
	Lung cancer vaccines to enhance immune checkpoint inhibitor therapy: evidence and future perspectives. J Hematol Oncol Tang Z, Zha L, Liang R, Li T. PMID: 41634728 [PubMed - as supplied by publisher]
	The molecular mechanism of IGF2BP3 promoting the malignant progression of lung cancer. Cancer Cell Int Wu C, Ma Y, Li J, Hai B, Zhou Y, Cao F, Kang X, Xu X. PMID: 41634702 [PubMed - as supplied by publisher]
	StructSAM: structure-aware prompt adaptation for robust lung cancer lesion segmentation in CT. NPJ Digit Med Liu M, Yao Y, Jia J, Yao J, Huang Z, Zeng Z, Pu G, Wu Y, Bai Y, Wang B, Jiang L. PMID: 41634130 [PubMed - as supplied by publisher]
	Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315). Eur J Cancer Althoff FC, Hummel HD, Kokowski K, Elender C, Grah C, Zacharias S, Fleitz A, Jänicke M, Groth A, Ludwig P, Nusch A, Reiser M, Pelz H, Wiegand J, Griesinger F, Thomas M, Eberhardt WEE, Sebastian M, CRISP Registry Group. PMID: 41633313 [PubMed - as supplied by publisher]
	Clinical characteristics and prognostic outcomes in KRAS-mutant non-small cell lung cancer: A real-world study with or without COPD comorbidity. Cancer Treat Res Commun Liao C, Wang Y, Bi Z, Chen H, Xu Y, Hu D, Luo R, Wang J, Xu Z, Li Y, Bai L. PMID: 41633085 [PubMed - as supplied by publisher]
	SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study. JCO Clin Cancer Inform Kosmidis PA, Kosmidis T, Papadopoulou K, Korfiatis N, Vozikis A, Lampaki S, Economopoulou P, Fountzilas E, Christopoulou A, Samantas E, Vagionas A, Mountzios GS, Goumas G, Tsoukalas N, Athanasiadis I, Bafaloukos D, Panopoulos C, Koufaki MI, Fountzilas G, Petrakis G, Linardou H. PMID: 41632937 [PubMed - indexed for MEDLINE]
	Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0. J Clin Oncol Reuss JE, Bazhenova L, Ismaila N, Abu Rous F, Ahluwalia A, Alluri K, Azar IH, Campbell T, Durm G, Feldman J, Florez N, Freeman-Daily J, Furuya N, Gadgeel S, Halmos B, Horinouchi H, Kuruvilla S, Macvicar GR, Malhotra N, Marrone KA, Mishra DR, Mullane M, Naidoo J, Owen DH, Pellini B, Presley CJ, Qin A, Roof L, Schenk EL, Sequist L, Singh N, Singhi EK, Suga JM, Velazquez AI, Wang Y, Wheatley Price P, Puri S, Leighl NB. PMID: 41632927 [PubMed - as supplied by publisher]
	Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0. J Clin Oncol Puri S, Leighl NB, Ismaila N, Rous FA, Ahluwalia A, Alluri K, Azar IH, Campbell T, Durm G, Feldman J, Florez N, Freeman-Daily J, Furuya N, Gadgeel S, Halmos B, Horinouchi H, Kuruvilla S, Macvicar GR, Malhotra N, Marrone KA, Mishra DR, Mullane M, Naidoo J, Owen DH, Pellini B, Presley CJ, Qin A, Roof L, Schenk EL, Sequist L, Singh N, Singhi EK, Suga JM, Velazquez AI, Wang Y, Price PW, Reuss JE, Bazhenova L. PMID: 41632926 [PubMed - as supplied by publisher]
	Safety and Efficacy of CT-Guided Lung Biopsy in Elderly Patients age 75 Years and Older: A Single-Centre Retrospective Comparative Study. Technol Cancer Res Treat Yoshimura S, Kanai O, Fujita K, Fujimoto N, Okada Y, Toyama S, Ito T, Imakita T, Oi I, Tanizawa K. PMID: 41632630 [PubMed - indexed for MEDLINE]
	Effects of two rehabilitation protocols on pulmonary function in lung cancer patients after thoracoscopic surgery: A randomized controlled trial of baduanjin versus bedside cycle ergometer training. Eur J Cardiothorac Surg Lu L, Shuhuan Y, Zuyuan Z, Xiang S, Ziyin Z, Li Z, Li L. PMID: 41632620 [PubMed - as supplied by publisher]
	EPIDSeg-Net: A Multi-Modal Fusion Framework Based on DRR Guidance in Radiotherapy is Used for Precise Segmentation of MV-EPID Lung Targets. Technol Cancer Res Treat Huang Q, Zhang H, Song L, Jiao Z, Ni X. PMID: 41632599 [PubMed - indexed for MEDLINE]
	Primary Pulmonary Hyalinizing Clear Cell Carcinoma: Diagnostic Challenges and Pathologic Features in a CT-Guided Biopsy Case. Pathol Int Wei L, Wang L, Wu X, Zheng D, Wei X. PMID: 41632551 [PubMed - indexed for MEDLINE]
	Validation of Claims-Based Algorithms to Classify Thoracic Radiation Therapy Courses. JCO Clin Cancer Inform Neibart SS, Lin N, Hogan J, Moningi S, Kann BH, Mak RH, Lam M. PMID: 41632523 [PubMed - indexed for MEDLINE]
	Effect of patient education in improving quality of life, fatigue and anxiety in people diagnosed with lung cancer: systematic review. Support Care Cancer Árbol-Guerrero LM, Ortega-Valle D, Fricke-Comellas H, Casuso-Holgado MJ, Muñoz-Fernández MJ, Martínez-Miranda P. PMID: 41632307 [PubMed - indexed for MEDLINE]
	Risk-Adapted Lung Cancer Screening Starting Ages for Former Smokers. JAMA Netw Open Frick C, Hallsson LR, Siebert U, Bhardwaj M, Schöttker B, Brenner H. PMID: 41632141 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 156083

Page 1 of 7805



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy